Sudarshan Pharma gains on getting nod to incorporate subsidiary in Poland
Sudarshan Pharma Industries is currently trading at Rs. 35.19, up by 0.20 points or 0.57% from its previous closing of Rs. 34.99 on the BSE.
The scrip opened at Rs. 35.40 and has touched a high and low of Rs. 35.40 and Rs. 33.40 respectively. So far 80000 shares were traded on the counter.
The BSE group 'MT' stock of face value Rs. 1 has touched a 52 week high of Rs. 53.50 on 07-Jan-2025 and a 52 week low of Rs. 5.82 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs. 35.40 and Rs. 31.92 respectively. The current market cap of the company is Rs. 819.44 crore.
The promoters holding in the company stood at 57.39%, while Institutions and Non-Institutions held 13.07% and 29.54% respectively.
Sudarshan Pharma Industries has received approval from Board of Directors to incorporate a Limited Liability Company namely ‘Sudarshan Pharma Poland’ in Poland, which will be a Wholly Owned Subsidiary (WOS) of the company. The company will subscribe 100 shares of Polish zloty 50 each (currency of Poland 'PLN') of the subsidiary aggregating to PLN 5,000 (around Rs 1,50,000) equivalent to 100.00% of the paid up share capital of subsidiary company.
The wholly owned subsidiary will carry on business of processing and preserving potatoes and to carry out production of basic organic and inorganic chemicals, fertilizers and nitrogen compounds, pesticides, disinfectants and other agrochemicals, soap and detergents, washing and cleaning agents, basic pharmaceutical substances, medicines and other pharmaceutical products and other chemical products and to act as wholesalers of perfumes, cosmetics, pharmaceutical and medical products.
The incorporation of Sudarshan Pharma Poland will allow the company to establish a place of business in the Republic of Poland.
Sudarshan Pharma Industries is engaged in contract manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.
